IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.
About IPO Scanner
IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.
Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.
Details of client bank account
For any query / feedback / clarifications, email at
[email protected].
Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.
© 2026 IPO Scanner. All rights reserved.
Want to stay updated?Subscribe to our newsletter
JATT II Acquisition Corp.
JATT II Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in healthcare and healthcare-related businesses.
The company was incorporated in 2026 and is based in Westfield, New Jersey.
Ticker, listing venue and issuer profile
Pricing terms and IPO milestones
Change from offer price to today
Real-time price; headline % change is vs first trade (listing price)
USD · NASDAQ:NASDAQ:JATT
Key valuation ratios and metrics
Balance sheet strength and liquidity
Volatility versus the market
Historical financial performance
Market history and supplemental quote data
| Date | Open | High | Low | Close | Adj. Close | Change | Volume |
|---|---|---|---|---|---|---|---|
| 2026-05-13 | $10.52 | $10.52 | $10.52 | $10.52 | $10.52 | 0.00 | 0 |
| 2026-05-12 | $10.52 | $10.52 | $10.52 | $10.52 | $10.52 | 0.00 | 0 |
| 2026-05-11 | $10.52 | $10.52 | $10.52 | $10.52 | $10.52 | 0.00 | 0 |
| 2026-05-08 | $10.50 | $10.53 | $10.50 | $10.52 | $10.52 | +0.02 | 1,600 |
| 2026-05-07 | $10.53 | $11.00 | $10.40 | $10.50 | $10.50 | -0.03 | 8,700 |
| 2026-05-06 | $10.51 | $10.52 | $10.50 | $10.51 | $10.51 | 0.00 | 700 |
| 2026-05-05 | $10.93 | $10.93 | $10.93 | $10.93 | $10.93 | 0.00 | 0 |
| 2026-05-04 | $10.52 | $10.93 | $10.50 | $10.93 | $10.93 | +0.41 | 1,100 |
| 2026-05-01 | $10.51 | $10.98 | $10.51 | $10.94 | $10.94 | +0.43 | 1,700 |
| 2026-04-30 | $11.31 | $11.31 | $10.50 | $10.50 | $10.50 | -0.81 | 1,900 |
| 2026-04-29 | $10.39 | $10.80 | $10.31 | $10.65 | $10.65 | +0.26 | 3,900 |
| 2026-04-28 | $10.50 | $10.92 | $10.50 | $10.92 | $10.92 | +0.42 | 1,200 |
| 2026-04-27 | $10.98 | $11.00 | $10.60 | $10.94 | $10.94 | -0.04 | 3,900 |
| 2026-04-24 | $10.60 | $10.67 | $10.49 | $10.50 | $10.50 | -0.10 | 3,500 |
| 2026-04-23 | $10.56 | $10.56 | $10.43 | $10.43 | $10.43 | -0.13 | 2,400 |
| 2026-04-22 | $10.40 | $10.76 | $10.25 | $10.54 | $10.54 | +0.14 | 94,100 |
| 2026-04-21 | $10.64 | $10.73 | $10.20 | $10.20 | $10.20 | -0.44 | 42,200 |
| 2026-04-20 | $10.50 | $10.50 | $10.10 | $10.25 | $10.25 | -0.25 | 24,800 |
| 2026-04-17 | $10.00 | $10.73 | $9.99 | $10.50 | $10.50 | +0.50 | 279,300 |
Official documents from SEC EDGAR
| Form | Filing Date | Document |
|---|---|---|
| SCHEDULE 13G | Apr 27, 2026 | Filing |
| 8-K | Apr 24, 2026 | Current Report |
| SCHEDULE 13G | Apr 24, 2026 | Filing |
| SCHEDULE 13G | Apr 24, 2026 | Filing |
| 8-K | Apr 21, 2026 | Current Report |
| 424B4 | Apr 17, 2026 | Prospectus |
| EFFECT | Apr 16, 2026 | Notice of Effectiveness |
| CERT | Apr 16, 2026 | Certification by an exchange approving securities for listing |
| 8-A12B | Apr 16, 2026 | Registration of securities |
| S-1/A | Apr 2, 2026 | [Amend] General form for registration of securities under the Securities Act of 1933 |
Contact and headquarters details
Key executives and officers
Dr. Someit Sidhu
Chairman, Director, and Chief Executive Officer
Nicholas Fernandez
Chief Financial Officer
Verender S. Badial
Director Nominee
Christopher Staral
Director Nominee
Dr. Arjun Goyal
Director Nominee
Dr. Jonathon Kluft
Director Nominee
USD · NASDAQ:JATT
Issue Size
$60.00M
Price Range
$10.00
Shares
7.8M o/s · 6M offered
Listing Price
$10.00
Listing date
Apr 17, 2026
Sector
Financials